Articles producció científica> Ciències Mèdiques Bàsiques

Quality assurance in radiotherapy: analysis of the causes of not starting or early radiotherapy withdrawal

  • Datos identificativos

    Identificador: imarina:5128617
    Autores:
    Arenas MSabater SGascón MHenríquez IBueno MRius ÀRovirosa ÀGómez DLafuerza ABiete AColomer J
    Resumen:
    Background: The aim of this study was to analyse the reasons for not starting or for early of radiotherapy at the Radiation Oncology Department. Methods: All radiotherapy treatments from March 2010 to February 2012 were included. Early withdrawals from treatment those that never started recorded. Clinical, demographic and dosimetric variables were also noted. Results: From a total of 3250 patients treated and reviewed, 121 (4%) did not start or complete the planned treatment. Of those, 63 (52%) did not receive any radiotherapy fraction and 58 (48%) did not complete the course, 74% were male and 26% were female. The mean age was 67 ± 13 years. The most common primary tumour was lung (28%), followed by rectum (16%). The aim of treatment was 62% radical and 38% palliative, 44% of patients had metastases; the most common metastatic site was bone, followed by brain. In 38% of cases (46 patients) radiotherapy was administered concomitantly with chemotherapy (10 cases (22%) were rectal cancers). Conclusions: The number of patients who did not complete their course of treatment is low, which shows good judgement in indications and patient selection. The most common reason for incomplete treatments was clinical progression. Rectal cancer treated with concomitant chemotherapy was the most frequent reason of the interruption of radiotherapy for toxicity. © Arenas et al.; licensee BioMed Central Ltd.
  • Otros:

    Autor según el artículo: Arenas M; Sabater S; Gascón M; Henríquez I; Bueno M; Rius À; Rovirosa À; Gómez D; Lafuerza A; Biete A; Colomer J
    Departamento: Ciències Mèdiques Bàsiques
    Autor/es de la URV: Arenas Prat, Meritxell
    Palabras clave: Trial Radiotherapy Quality assurance Older patients Not starting treatments Experience Elderly-patients Early withdrawal treatments Discontinuation Capecitabine Breast-cancer patients Advanced rectal-cancer Adjuvant radiotherapy 1st-line chemotherapy
    Resumen: Background: The aim of this study was to analyse the reasons for not starting or for early of radiotherapy at the Radiation Oncology Department. Methods: All radiotherapy treatments from March 2010 to February 2012 were included. Early withdrawals from treatment those that never started recorded. Clinical, demographic and dosimetric variables were also noted. Results: From a total of 3250 patients treated and reviewed, 121 (4%) did not start or complete the planned treatment. Of those, 63 (52%) did not receive any radiotherapy fraction and 58 (48%) did not complete the course, 74% were male and 26% were female. The mean age was 67 ± 13 years. The most common primary tumour was lung (28%), followed by rectum (16%). The aim of treatment was 62% radical and 38% palliative, 44% of patients had metastases; the most common metastatic site was bone, followed by brain. In 38% of cases (46 patients) radiotherapy was administered concomitantly with chemotherapy (10 cases (22%) were rectal cancers). Conclusions: The number of patients who did not complete their course of treatment is low, which shows good judgement in indications and patient selection. The most common reason for incomplete treatments was clinical progression. Rectal cancer treated with concomitant chemotherapy was the most frequent reason of the interruption of radiotherapy for toxicity. © Arenas et al.; licensee BioMed Central Ltd.
    Áreas temáticas: Saúde coletiva Radiology, nuclear medicine and imaging Radiology, nuclear medicine & medical imaging Oncology Odontología Medicina iii Medicina ii Medicina i Engenharias ii Ciências biológicas ii Ciências biológicas i Astronomia / física
    Acceso a la licencia de uso: https://creativecommons.org/licenses/by/3.0/es/
    Direcció de correo del autor: meritxell.arenas@urv.cat
    Identificador del autor: 0000-0003-0815-2570
    Fecha de alta del registro: 2024-09-07
    Versión del articulo depositado: info:eu-repo/semantics/publishedVersion
    Enlace a la fuente original: https://ro-journal.biomedcentral.com/articles/10.1186/s13014-014-0260-0
    URL Documento de licencia: https://repositori.urv.cat/ca/proteccio-de-dades/
    Referencia al articulo segun fuente origial: Radiation Oncology. 9 (1):
    Referencia de l'ítem segons les normes APA: Arenas M; Sabater S; Gascón M; Henríquez I; Bueno M; Rius À; Rovirosa À; Gómez D; Lafuerza A; Biete A; Colomer J (2014). Quality assurance in radiotherapy: analysis of the causes of not starting or early radiotherapy withdrawal. Radiation Oncology, 9(1), -. DOI: 10.1186/s13014-014-0260-0
    DOI del artículo: 10.1186/s13014-014-0260-0
    Entidad: Universitat Rovira i Virgili
    Año de publicación de la revista: 2014
    Tipo de publicación: Journal Publications
  • Palabras clave:

    Oncology,Radiology, Nuclear Medicine & Medical Imaging,Radiology, Nuclear Medicine and Imaging
    Trial
    Radiotherapy
    Quality assurance
    Older patients
    Not starting treatments
    Experience
    Elderly-patients
    Early withdrawal treatments
    Discontinuation
    Capecitabine
    Breast-cancer patients
    Advanced rectal-cancer
    Adjuvant radiotherapy
    1st-line chemotherapy
    Saúde coletiva
    Radiology, nuclear medicine and imaging
    Radiology, nuclear medicine & medical imaging
    Oncology
    Odontología
    Medicina iii
    Medicina ii
    Medicina i
    Engenharias ii
    Ciências biológicas ii
    Ciências biológicas i
    Astronomia / física
  • Documentos:

  • Cerca a google

    Search to google scholar